Danish biotech Egalet pitches $69M IPO on Nasdaq – FierceBiotech
|
Danish biotech Egalet pitches $ 69M IPO on Nasdaq
FierceBiotech A Danish biotech company with a foothold in the U.S. is making a bid to cash in on the big IPO boom on Nasdaq. Egalet, which has been developing abuse-resistant opioid pain pills, has outlined plans to raise $ 69 million from an initial offering. That … |
